OtherCommentary
A Biopharmaceutical Industry Perspective on the Control of Visible Particles in Biotechnology Derived Injectable Drug Products
Serge Mathonet, Hanns-Chistian Mahler, Stefan T. Esswein, Maryam Mazaheri, Patricia W. Cash, Klaus Wuchner, Goerg Kallmeyer, Tapan Das, Christof Finkler and Andrew Lennard
PDA Journal of Pharmaceutical Science and Technology April 2016, pdajpst.2015.006189; DOI: https://doi.org/10.5731/pdajpst.2015.006189
Serge Mathonet
1 Sanofi;
Hanns-Chistian Mahler
2 Lonza;
Stefan T. Esswein
3 Abbvie;
Maryam Mazaheri
4 medimmune;
Patricia W. Cash
4 medimmune;
Klaus Wuchner
5 Janssen R&D;
Goerg Kallmeyer
6 La Roche Ltd;
Tapan Das
7 Bristol Myers Squibb;
Christof Finkler
6 La Roche Ltd;
Andrew Lennard
8 Amgen
In This Issue
PDA Journal of Pharmaceutical Science and Technology
Vol. 78, Issue 2
March/April 2024
A Biopharmaceutical Industry Perspective on the Control of Visible Particles in Biotechnology Derived Injectable Drug Products
Serge Mathonet, Hanns-Chistian Mahler, Stefan T. Esswein, Maryam Mazaheri, Patricia W. Cash, Klaus Wuchner, Goerg Kallmeyer, Tapan Das, Christof Finkler, Andrew Lennard
PDA Journal of Pharmaceutical Science and Technology Apr 2016, pdajpst.2015.006189; DOI: 10.5731/pdajpst.2015.006189
A Biopharmaceutical Industry Perspective on the Control of Visible Particles in Biotechnology Derived Injectable Drug Products
Serge Mathonet, Hanns-Chistian Mahler, Stefan T. Esswein, Maryam Mazaheri, Patricia W. Cash, Klaus Wuchner, Goerg Kallmeyer, Tapan Das, Christof Finkler, Andrew Lennard
PDA Journal of Pharmaceutical Science and Technology Apr 2016, pdajpst.2015.006189; DOI: 10.5731/pdajpst.2015.006189
Jump to section
Related Articles
- No related articles found.
Cited By...
- Characterization of a Novel Particle in a Pharmaceutical Drug Product
- Development and Qualification of Visible Particle Load Analysis Methods for Injectable Drug Product Primary Packaging Components
- Micro-Flow Imaging: Estimation of the Contribution of Key Factors to the Variability of Subvisible Particle Count Measurement by a Nested Statistical Analysis
- Development of Protein-Like Reference Material for Semiquantitatively Monitoring Visible Proteinaceous Particles in Biopharmaceuticals
- Achieving "Zero" Defects for Visible Particles in Injectables
More in this TOC Section
Similar Articles
Keywords